OCT 08, 2020 12:00 PM PDT

ZooMAb® Antibodies- a Novel Recombinant Antibody Technology

Sponsored by: MilliporeSigma
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Head of Antibody Development
    Biography

      Dr. Wayne Speckmann has been working in R&D for over 20 years and is an expert in antibody development and immunoassays.


    Abstract

    Antibodies have become one of the most important tools in life science research, allowing the detection, quantitation, and determination of changes in proteins and other molecules with respect to time and subcellular location.  MilliporeSigma ZooMAb® antibodies represent a new generation of monoclonal antibodies that are specifically engineered using proprietary technologies that provide state-of-the-art consistency and applications performance.  ZooMAb® antibodies are designed with the most user-friendly formulation, handling, and storage features available today and have been validated in multiple immunoassay applications.  This platform acquired its unique name because of its proprietary B cell immortalization technology that also allows us to produce monoclonal antibodies from a wide range of species including rabbits, goats, llama, sheep, and more.  The monoclonal antibodies produced and selected are subsequently converted into a eukaryotic recombinant expression format.  Thus, all ZooMAb® antibodies are offered as affinity purified recombinant proteins for highest reproducibility, purity, and performance.  In this webinar, we will highlight the development process of ZooMAb® antibodies, show examples of the outstanding affinity, avidity, and specificity of these antibodies in multiple immunoassays, provide details about the earth friendly format they are provided in, and finally deliver details about future directions as well as custom development opportunities.

    Learning Objectives:

    1. Learn about advantages of recombinant antibodies in cancer research

    2. Learn about ZooMAb antibodies  - MilliporeSigma's recombinant monoclonal antibody line


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    Loading Comments...
    Show Resources